As for NDD-CKD patients, the use of daprodustat significantly reduced the levels of hepcidin and ferritin as well as serum total iron, suggesting that the body’s iron storage and available iron were decreased after the treatment. The gene discussed is HAMP; the disease is chronic kidney disease.